The art and design of genetic screens: Mammalian culture cells

Nature Reviews Genetics

Volumn 5, Issue 3, 2004, Pages 179-189

  Grimm, Stefan ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; CAENORHABDITIS ELEGANS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL TRANSFORMATION; COMPARATIVE STUDY; DROSOPHILA; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC COMPLEMENTATION; GENETIC MODEL; GENETIC SCREENING; GENETIC TRANSFECTION; MAMMAL CELL; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; ROBOTICS; SENESCENCE;

ANIMALS; CAENORHABDITIS ELEGANS; CELL CULTURE TECHNIQUES; CHO CELLS; COS CELLS; CRICETINAE; DROSOPHILA; GENE EXPRESSION PROFILING; GENE TRANSFER TECHNIQUES; GENES, DOMINANT; GENES, REPORTER; HELA CELLS; HUMANS; JURKAT CELLS; MAMMALS;

ANIMALIA; CAENORHABDITIS; CAENORHABDITIS ELEGANS; MAMMALIA;

EID: 1542320541     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1291     Document Type: Review

References (137)

1. Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
2. Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001). References 1 and 2 present the human genome sequence and lay out the inventory of human genes.
3. Eagle, H. Amino add metabolism in human cell cultures. Science 130, 432-436 (1959).
4. Aravind, L., Dixit, V. M. & Koonin, E. V. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291, 1279-1284 (2001).
5. Horrocks, C., Halse, R., Suzuki, R. & Shepherd, P. R. Human cell systems for drug discovery. Curr. Opin. Drug Discov. Devel. 6, 570-575 (2003).
6. Masters, J. R. Human cancer cell lines: fact and fantasy. Nature Rev. Mol. Cell Biol. 1, 233-236 (2000).
7. Liu, D., Yang, X., Yang, D. & Songyang, Z. Genetic screens in mammalian cells by enhanced retroviral mutagens. Oncogene 19, 5964-5972 (2000).
8. Klinakis, A. G., Zagoraiou, L., Vassilatis, D. K. & Savakis, C. Genome-wide insertional mutagenesis in human cells by the Drosophila mobile element Minos. EMBO Rep. 1, 416-421 (2000).
9. Harrington, J. J. et al. Creation of genome-wide protein expression libraries using random activation of gene expression. Nature Biotechnol. 19, 440-445 (2001).
10. Ishida, Y. & Leder, P. RET: a poly A-trap retrovirus vector for reversible disruption and expression monitoring of genes in living cells. Nucleic Acids Res. 27, e35 (1999).
11. Whitney, M. et al. A genome-wide functional assay of signal transduction in living mammalian cells. Nature Biotechnol. 16, 1329-1333 (1998).
12. Gudkov, A. V. & Roninson, I. B. Isolation of genetic suppressor elements (GSEs) from random fragment cDNA libraries in retroviral vectors. Methods Mol. Biol. 69, 221-240 (1997).
13. Suyama, E., Kawasaki, H., Nakajima, M. & Taira, K. Identification of genes involved in cell invasion by using a library of randomized hybrid ribozymes. Proc. Natl Acad. Sci. USA 100, 5616-5621 (2003).
14. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
15. Taylor, M. F., Wiederholt, K. & Sverdrup, F. Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination. Drug Discov. Today 4, 562-567 (1999).
16. Yonekura, H. et al. Antisense display: a new method for functional gene screen and its application to angiogenesis-related gene isolation. Ann. NY Acad. Sci. 947, 382-386 (2001).
17. Baker, E. K. et al. A genetic analysis of integrin function: glanzmann thrombasthenia in vitro. Proc. Natl Acad. Sci. USA 94, 1973-1978 (1997).
18. Watanabe, M. et al. Molecular cloning of the human gene, CCG2, that complements the BHK-derived temperature-sensitive cell cycle mutant tsBN63: identity of CCG2 with the human X chromosomal SCAR/RPS4X gene. J. Cell Sci. 100, 35-43 (1991).
19. McKendry, R. et al. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both α and γ interferons. Proc. Natl Acad. Sci. USA 88, 11455-11459 (1991).
20. Weissman, B. E. et al, Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236, 175-180 (1987).
21. Anderson, M. J. & Stanbridge, E. J. Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J. 7, 826-833 (1993).
22. Nusslein-Volhard, C. & Wieschaus, E. Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801 (1980).
23. Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71-94 (1974).
24. Horvitz, H. R. & Sulston, J. E. Isolation and genetic characterization of cell-lineage mutants of the nematode Caenorhabditis elegans. Genetics 96, 435-454 (1980).
25. Haffter, P. et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36 (1996).
26. Driever, W. et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123, 37-46 (1996).
27. Hengartner, M. O. The biochemistry of apoptosis. Nature 407, 770-776 (2000).
28. Tominaga, K., Olgun, A., Smith, J. R. & Pereira-Smith, O. M. Genetics of cellular senescence. Mech. Ageing Dev. 123, 927-936 (2002).
29. Seed, B. Developments in expression cloning. Curr. Opin. Biotechnol. 6, 567-573 (1995).
30. Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178 (1993).
31. Pennica, D. et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl Acad. Sci. USA 92, 1142-1146 (1995).
32. Kim, C. M., Goldstein, J. L. & Brown, M. S. cDNA cloning of MEV, a mutant protein that facilitates cellular uptake of mevalonate, and identification of the point mutation responsible for its gain of function. J. Biol. Chem. 267, 23113-23121 (1992).
33. Wu, L. et al. Expression cloning and characterization of human 17 β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 α-hydroxysteroid dehydrogenase activity. J. Biol. Chem. 268, 12964-12969 (1993).
34. Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M. & Masucci, M. G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nature Biotechnol. 18, 538-543 (2000).
35. Xu, X. et al. Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res. 26, 2034-2035 (1998).
36. Llopis, J., McCaffery, J. M., Miyawaki, A., Farquhar, M. G. & Tsien, R. Y. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl Acad. Sci. USA 95, 6803-6808 (1998).
37. Simpson, J. C., Wellenreuther, R., Poustka, A., Pepperkok, R. & Wiemann, S. Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 1, 287-292 (2000).
38. Misawa, K. et al. A method to identify cDNAs based on localization of green fluorescent protein fusion products. Proc. Natl Acad. Sci. USA 97, 3062-3066 (2000).
39. Un, S. Y. & Elledge, S. J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889 (2003).
40. Gorman, C. M., Moffat, L. F. & Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2, 1044-1051 (1982).
41. Zlokarnik, G. et al. Quantitation of transcription and clonal selection of single living cells with β-lactamase as reporter. Science 279, 84-88 (1998).
42. Matsuda, A. et al. Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways. Oncogene 22, 3307-3318 (2003).
43. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996). Excellent example of an inventive use of reporter plasmids.
44. Rossi, F., Charlton, C. A. & Blau, H. M. Monitoring protein-protein interactions in intact eukaryotic cells by β-galactosidase complementation. Proc. Natl Acad. Sci. USA 94, 8405-8410 (1997).
45. Remy, I. & Michnick, S. W. Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. Proc. Natl Acad. Sci. USA 96, 5394-5399 (1999).
46. Remy, I. & Michnick, S. W. Visualization of biochemical networks in living cells. Proc. Natl Acad. Sci. USA 98, 7678-7683 (2001).
47. Shioda, T., Andriole, S., Yahata, T. & Isselbacher, K. J. A green fluorescent protein-reporter mammalian two-hybrid system with extrachromosomal maintenance of a prey expression plasmid: application to interaction screening. Proc. Natl Acad. Sci. USA 97, 5220-5224 (2000).
48. Ozawa,T., Nogami, S., Sato, M., Ohya, Y. & Umezawa, Y. A fluorescent indicator for detecting protein-protein interactions in vivo based on protein splicing. Anal. Chem. 72, 5151-5157 (2000).
49. Ozawa, T., Sako, Y., Sato, M., Kitamura, T. & Umezawa, Y. A genetic approach to identifying mitochondrial proteins. Nature Biotechnol. 21, 287-293 (2003).
50. Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 65, 5187-5190 (1995).
51. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001).
52. Simonsen, H. & Lodish, H. F. Cloning by function: expression cloning in mammalian cells. Trends Pharmacolog. Sci. 15, 437-441 (1994).
53. Dowdy, S. F. et al. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. Science 254, 293-295 (1991).
54. Wong, G. G. et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228, 810-815 (1985).
55. Tsai, S. F. et al. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339, 446-451 (1989).
56. Hoffman, B. J., Mezey, E. & Brownstein, M. J. Cloning of a serotonin transporter affected by antidepressants. Science 254, 579-580 (1991).
57. Paulmichl, M. et al. New mammalian chloride channel identified by expression cloning. Nature 356, 238-241 (1992).
58. + channel is made of three homologous subunits. Nature 367, 463-467 (1994).
59. D'Andrea, A. D., Lodish, H. F. & Wong, G. G. Expression cloning of the murine erythropoietin receptor. Cell 57, 277-285 (1989).
60. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A. & Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785 (1992).
61. Wang, X. F. et al. Expression cloning and characterization of the TGF-β type III receptor. Cell 67, 797-4305 (1991).
62. Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297, 474-478 (1982).
63. Goldfarb, M., Shimizu, K., Perucho, M. & Wigler, M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296, 404-409 (1982).
64. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689 (1989).
65. Miki, T. et al. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251, 72-75 (1991).
66. Chan, A. M. et al. Expression cDNA cloning of a serine kinase transforming gene. Oncogene 8, 1329-1333 (1993).
67. Chan, A. M., Takal, S., Yamada, K. & Miki, T. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Oncogene 12, 1259-1266 (1996).
68. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 188, 593-602 (1997).
69. Leszczyniecka, M. et al. Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence. Proc. Natl Acad. Sci. USA 99, 16636-16641 (2002).
70. Stark, G. R. & Gudkov, A. V. Forward genetics in mammalian cells: functional approaches to gene discovery. Hum. Mol. Genet. 8, 1925-1938 (1999).
71. Ting, A. T., Pimentel-Muinos, F. X. & Seed, B. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/ APO-1-initiated apoptosis. EMBO J. 15, 6189-6196 (1996).
72. Fenczik, C. A., Sethi, T., Ramos, J. W., Hughes, P. E. & Ginsberg, M. H. Complementation of dominant suppression implicates CD98 in integrin activation. Nature 390, 81-85 (1997).
73. Watling, D. et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature 386, 166-170 (1993).
74. Muller, M. et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and-γ signal transduction pathways. EMBO J. 12, 4221-4228 (1993).
75. Thompson, L. H., Brookman, K. W., Jones, N. J., Allen, S. A. & Carrano, A. V. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol. Cell Biol. 10, 6160-6171 (1990).
76. Simons, A., Dafni, N., Dotan, I., Oron, Y. & Canaani, D. Establishment of a chemical synthetic lethality screen in cultured human cells. Genome Res. 11, 266-273 (2001).
77. Simons, A. H., Dafni, N., Dotan, I., Oron, Y. & Canaani, D. Genetic synthetic lethality screen at the single gene level in cultured human cells. Nucleic Acids Res. 29, E100 (2001).
78. Schmitz, M. L. & Baeuerle, P. A. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10, 3805-3817 (1991).
79. Crameri, A., Raillard, S. A., Bermudez, E. & Stemmer, W. P. DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 391, 288-291 (1998).
80. Crameri, A., Whitehorn, E. A., Tate, E. & Stemmer, W. P. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nature Biotechnol. 14, 315-319 (1996).
81. Leong, S. R. et al. Optimized expression and specific activity of IL-12 by directed molecular evolution. Proc. Natl Acad. Sci. USA 100, 1163-1168 (2003).
82. Coco, W. M. et al. Growth factor engineering by degenerate homoduplex gene family recombination. Nature Biotechnol. 20, 1246-1250 (2002).
83. Drews, J. Drug discovery: a historical perspective. Science 287, 1960-1964 (2000).
84. Stockwell, B. R. Chemical genetics: ligand-based discovery of gene function. Nature Rev. Genet. 1, 116-125 (2000).
85. Hauptschein, R. S., Eustase, B. K. & Jay, D. G. Global high-throughput screens for cellular function. Exp. Hematol. 30, 381-387 (2002).
86. Mayer, T. U. et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971-974 (1999).
87. Hanes, J., Schaffitzel, C., Knappik, A. & Pluckthun, A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nature Biotechnol. 18,1287-1292 (2000).
88. Rajfur, Z., Roy, P., Otey, C., Romer, L. & Jacobson, K. Dissecting the link between stress fibres and focal adhesions by CAU with EGFP fusion proteins. Nature Cell Biol. 4, 286-293 (2002).
89. Marek, K. W. & Davis, G. W. Transgenically encoded protein photoinactivation (FlAsH-FALI): acute inactivation of synaptotagmin I. Neuron 36, 805-813 (2002).
90. Gaietta, G. et al. Multicolor and electron microscopic imaging of connexin trafficking. Science 296, 503-507 (2002).
91. Jay, D. G. Selective destruction of protein function by chromophore-assisted laser inactivation. Proc. Natl Acad. Sci. USA 85, 5454-5458 (1988). First report of antibody-mediated knock-out using a laser.
92. Beck, S. et al. Fluorophore-assisted light inactivation: a high-throughput tool for direct target validation of proteins. Proteomics 2, 247-255 (2002).
93. Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411,107-110 (2001). Describes the establishment of genetic screening using the cell microarray technique.
94. Albayrak, T. & Grimm, S. A high-throughput screen for single gene activities: isolation of apoptosis inducers. Biochem. Biophys. Res. Commun. 304, 772-776 (2003).
95. Grimm, S. & Kachel, V. Robotic high-throughput assay for isolating apoptosis-inducing genes. Biotechniques 32, 670-672, 674-677 (2002).
96. Neudecker, F. & Grimm, S. High-throughput method for isolating plasmid DNA with reduced lipopolysaccharide content Biotechniques. 28, 107-109 (2000).
97. Bauer, M. K. A., Schubert, A., Rocks, O. & Grimm, S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J. Cell Biol. 147, 1493-1502 (1999).
98. Marzo, I. et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187, 1261-1271 (1998).
99. Abayrak, T. et al. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol. Biol. Cell 14, 3082-3096 (2003). Presentation of the use of the RISCI screening method for the detection of apoptosis inducers.
100. Mund, T., Gewies, A., Schoenfeld, N., Bauer, M. K. & Grimm, S. Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum. FASEB J. 17, 696-698 (2003).
101. Schoenfeld, N., Bauer, M. K. & Grimm, S. The metastasis suppressor gene C33/CD82/KAl1 induces apoptosis through reactive oxygen intermediates. FASEB J. 18, 158-160 (2004).
102. Michiels, F. et al. Arrayed adenoviral expression libraries for functional screening. Nature Biotechnol. 20, 1154-1157 (2002). Shows the use of a pre-defined virus library to clone differentiation-inducing genes.
103. Sharp, P. A. RNAi and double-strand RNA. Genes Dev. 13, 139-141 (1999).
104. Kumar, R., Conklin, D. S. & Mittal, V. High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 13, 2333-2340 (2003).
105. Mousses, S. et al. RNAi microarray analysis in cultured mammalian cells. Genome Res. 13, 2341-2347 (2003).
106. Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627-637 (2003).
107. Strausberg, R. L., Feingold, E. A., Klausner, R. D. & Collins, F. S. The mammalian gene collection. Science 286, 455-457 (1999).
108. Okasaki, Y. et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420, 563-573 (2001).
109. Frankish, H. Consortium uses RNAi to uncover genes' function. Lancet 361, 584 (2003).
110. Bleicher, K. H., Bohm, H. J., Muller, K. & Alanine, A. I. Hit and lead generation: beyond high-throughput screening. Nature Rev. Drug Discov. 2, 369-378 (2003).
111. Beske, O. E. & Goldbard, S. High-throughput cell analysis using multiplexed array technologies. Drug Discov. Today 7, S131-135 (2002).
112. Ibrahim, S. F. & van den Engh, G. High-speed cell sorting: fundamentals and recent advances. Curr. Opin. Biotechnol. 14, 5-12 (2003).
113. Chovan, T. & Guttman, A. Microfabricated devices in biotechnology and biochemical processing. Trends Biotechnol. 20, 116-122 (2002).
114. Dauty, E., Remy, J. S., Blessing, T. & Behr, J. P. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J. Am. Chem. Soc. 123, 9227-9234 (2001).
115. Feigner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413-7417 (1987).
116. Graham, F. L. & van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467 (1973).
117. Vaheri, A. & Pagano, J. S. Infectious poliovirus RNA: a sensitive method of assay. Virology 27, 434-436 (1965).
118. Wong, T. K. & Neumann, E. Electric field mediated gene transfer. Biochem. Biophys. Res. Commun. 107, 584-587 (1982).
119. Seed, B. & Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl Acad. Sci. USA 84, 3365-3389 (1987). First description of expression cloning in mammalian cells.
120. Hirt, B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369 (1967).
121. Grimm, S. & Leder, P. An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes. J. Exp. Med. 185, 1137-1142 (1997).
122. Schubert, A. & Grimm, S. Cyclophilin D, a component of the permeability transition (PT)-pore, is an apoptosis repressor. Cancer Res. 64, 85-93 (2004).
123. Untergasser, G., Koch, H. B., Menssen, A. & Hermeking, H. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res. 62, 6255-6262 (2002).
124. Scherer, W. F., Syverton, J. T. & Gey, G. O. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J. Exp. Med. 97, 695-710 (1953).
125. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74 (1977).
126. Soule, H. D., Vazguez, J., Long, A., Albert, S. & Brannan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51, 1409-1416 (1973),
127. Fogh, J., Wright, W. C. & Loveless, J. D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl Cancer Inst. 58, 209-214 (1977).
128. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F. & Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 17, 16-23 (1979).
129. Schneider, U., Schwenk, H. U. & Bomkamm, G. Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19, 621-626 (1977).
130. Gluzman, Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175-182 (1981).
131. Hopps, H. E., Bernheim, B. C., Nisalak, A., Tjio, J. H. & Smadel, J. E. Biologic characteristics of a continuous kidney cell line derived from the African green monkey. J. Immunol. 91, 416-424 (1963).
132. Kao, F. T. & Puck, T. T. Genetics of somatic mammalian cells, VII. Induction and isolation of nutritional mutants in Chinese hamster cells. Proc. Natl Acad. Sci. USA 60, 1275-1281 (1968).
133. Sanford, K. K., Earle, W. R. & Likely, G. D. The growth in vitro of single isolated tissue cells. J. Natl Cancer Inst 9, 299-246 (1948).
134. Todaro, G. J. & Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299-313 (1963).
135. Macpherson, I. & Stoker, M. Polyoma transformation of hamster cell clones - an investigation of genetic factors affecting cell competence. Virology 16, 147-151 (1962).
136. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756 (1973).
137. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. & Kemler, R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27-45 (1985).